This inventor holds 1 USPTO granted patent and 4 published patent applications, plus 1 CIPO patent. Top assignee: Illumina Corporation. Active years: 2023.
Company Filing History:
Years Active: 2023
Title: Come Raczy: Innovator in Nucleotide Sequencing Analysis
Introduction
Come Raczy is a notable inventor based in Del Mar, California. He has made significant contributions to the field of genetic analysis through his innovative patent. His work focuses on enhancing the efficiency of secondary analyses of nucleotide sequencing data.
Latest Patents
Come Raczy holds a patent for a "System and method for secondary analysis of nucleotide sequencing data." This patent discloses systems and methods for performing secondary analyses in a time-efficient manner. Some embodiments of the invention include performing secondary analysis iteratively while sequence reads are generated by a sequencing system. The secondary analyses can encompass alignment of sequence reads to a reference sequence, such as the human reference genome sequence, and utilize this alignment to detect differences between a sample and the reference. This analysis enables the detection of genetic differences, variant detection and genotyping, identification of single nucleotide polymorphisms (SNPs), small insertions and deletions (indels), and structural changes in DNA, including copy number variants (CNVs) and chromosomal rearrangements. Come Raczy has 1 patent to his name.
Career Highlights
Come Raczy is associated with Illumina Corporation, a leading company in the field of genomics. His work at Illumina has allowed him to contribute to advancements in genetic research and technology.
Collaborations
Some of his notable coworkers include Francisco Jose Garcia and Aaron Day. Their collaboration has likely fostered an environment of innovation and progress in their respective fields.
Conclusion
Come Raczy's contributions to nucleotide sequencing analysis exemplify the impact of innovative thinking in the field of genetics. His patent reflects a commitment to improving the efficiency and accuracy of genetic analysis, paving the way for future advancements.
